Discontinued — last reported Q1 '26
Merck & Co. Animal Health — Sales increased by 19.0% to $1.79B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.8%, from $1.59B to $1.79B. Over 4 years (FY 2021 to FY 2025), Animal Health — Sales shows an upward trend with a 3.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth indicates successful product adoption and market expansion, while decline suggests competitive pressure or market saturation.
Total revenue generated from the sale of animal health products, including vaccines, parasiticides, and pharmaceuticals...
Standard revenue metric for all public companies with distinct operating segments.
mrk_segment_animal_health_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.47B | $1.42B | $1.26B | $1.48B | $1.47B | $1.37B | $1.23B | $1.49B | $1.46B | $1.40B | $1.28B | $1.51B | $1.48B | $1.49B | $1.40B | $1.59B | $1.65B | $1.62B | $1.51B | $1.79B |
| QoQ Change | — | -3.7% | -11.0% | +17.5% | -1.0% | -6.5% | -10.3% | +21.2% | -2.3% | -3.8% | -8.7% | +18.2% | -1.9% | +0.3% | -6.1% | +13.7% | +3.7% | -1.9% | -6.8% | +19.0% |
| YoY Change | — | — | — | — | -0.3% | -3.2% | -2.5% | +0.6% | -0.7% | +2.1% | +3.9% | +1.3% | +1.8% | +6.2% | +9.3% | +5.1% | +11.1% | +8.6% | +7.7% | +12.8% |